Dopamine Signaling Is Essential for Precise Rates of Locomotion by C. elegans

Dopamine is an important neuromodulator in both vertebrates and invertebrates. We have found that reduced dopamine signaling can cause a distinct abnormality in the behavior of the nematode C. elegans, which has only eight dopaminergic neurons. Using an automated particle-tracking system for the analysis of C. elegans locomotion, we observed that individual wild-type animals made small adjustments to their speed to maintain constant rates of locomotion. By contrast, individual mutant animals defective in the synthesis of dopamine made larger adjustments to their speeds, resulting in large fluctuations in their rates of locomotion. Mutants defective in dopamine signaling also frequently exhibited both abnormally high and abnormally low average speeds. The ability to make small adjustments to speed was restored to these mutants by treatment with dopamine. These behaviors depended on the D2-like dopamine receptor DOP-3 and the G-protein subunit GOA-1. We suggest that C. elegans and other animals, including humans, might share mechanisms by which dopamine restricts motor activity levels and coordinates movement.

[1]  S. Udenfriend,et al.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.

[2]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[3]  George C. Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[4]  R. M. Filho,et al.  [L-dopa in Parkinson's syndrome]. , 1971, Revista brasileira de medicina.

[5]  S. Ward.  Chemotaxis by the nematode Caenorhabditis elegans: identification of attractants and analysis of the response by use of mutants. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. L. Russell,et al.  Normal and mutant thermotaxis in the nematode Caenorhabditis elegans. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Sulston,et al.  Dopaminergic neurons in the nematode Caenorhabditis elegans , 1975, The Journal of comparative neurology.

[8]  S. Brenner,et al.  The structure of the ventral nerve cord of Caenorhabditis elegans. , 1976, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[9]  J. Culotti,et al.  Osmotic avoidance defective mutants of the nematode Caenorhabditis elegans. , 1978, Genetics.

[10]  S. Brenner,et al.  The structure of the nervous system of the nematode Caenorhabditis elegans. , 1986, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[11]  N. Munakata.  [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[12]  Cori Bargmann,et al.  Chemosensory neurons with overlapping functions direct chemotaxis to multiple chemicals in C. elegans , 1991, Neuron.

[13]  Cori Bargmann,et al.  Odorant-selective genes and neurons mediate olfaction in C. elegans , 1993, Cell.

[14]  A. Alfonso,et al.  The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. , 1993, Science.

[15]  Jeremy Mendel,et al.  Participation of the protein Go in multiple aspects of behavior in C. elegans , 1995, Science.

[16]  L. Ségalat,et al.  Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans , 1995, Science.

[17]  Elizabeth Rachel Sawin,et al.  Genetic and cellular analysis of modulated behaviors in Caenorhabditis elegans , 1996 .

[18]  Ikue Mori,et al.  Mutations in a Cyclic Nucleotide–Gated Channel Lead to Abnormal Thermosensation and Chemosensation in C. elegans , 1996, Neuron.

[19]  L. Avery,et al.  Guanylyl cyclase expression in specific sensory neurons: a new family of chemosensory receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Watts.  The role of dopamine agonists in early Parkinson's disease , 1997, Neurology.

[21]  The changing standard of care in Parkinson's disease , 1997, Neurology.

[22]  I. Tulloch.  Pharmacologic profile of ropinirole , 1997, Neurology.

[23]  E. Jorgensen,et al.  Identification and characterization of the vesicular GABA transporter , 1997, Nature.

[24]  Cori Bargmann.  Neurobiology of the Caenorhabditis elegans genome. , 1998, Science.

[25]  S. W. Emmons,et al.  Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFbeta family signaling pathway and a Hox gene. , 1999, Development.

[26]  F. Hamdan,et al.  Characterization of a Novel Serotonin Receptor from Caenorhabditis elegans , 1999, Journal of neurochemistry.

[27]  Rajesh Ranganathan,et al.  C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway , 2000, Neuron.

[28]  H. Horvitz,et al.  Mutations in the Caenorhabditis elegans Serotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine , 2001, The Journal of Neuroscience.

[29]  R. Komuniecki,et al.  Characterization of a tyramine receptor from Caenorhabditis elegans , 2002, Journal of Neurochemistry.

[30]  M. Solanto.  Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research , 2002, Behavioural Brain Research.

[31]  M. Labouesse.  [Caenorhabditis elegans]. , 2003, Medecine sciences : M/S.

[32]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[33]  Shalini Jha,et al.  The diagnosis of Parkinson's disease. , 2003, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[34]  R. Wise.  Dopamine, learning and motivation , 2004, Nature Reviews Neuroscience.

[35]  Michael R Koelle,et al.  Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans , 2004, Nature Neuroscience.

[36]  D. van der Kooy,et al.  Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans , 2004, The EMBO journal.

[37]  A. V. Maricq,et al.  Dopamine and Glutamate Control Area-Restricted Search Behavior in Caenorhabditis elegans , 2004, The Journal of Neuroscience.

[38]  M. Hallett,et al.  Levodopa in the treatment of Parkinson's disease: Current controversies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[39]  Cornelia I. Bargmann,et al.  Oxygen sensation and social feeding mediated by a C. elegans guanylate cyclase homologue , 2004, Nature.

[40]  Cornelia I. Bargmann,et al.  Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans , 2005, Nature.

[41]  J. Sze,et al.  Serotonin (5HT), Fluoxetine, Imipramine and Dopamine Target Distinct 5HT Receptor Signaling to Modulate Caenorhabditis elegans Egg-Laying Behavior , 2005, Genetics.

[42]  O. Hornykiewicz,et al.  The discovery of dopamine deficiency in the parkinsonian brain. , 2006, Journal of neural transmission. Supplementum.

[43]  Aravinthan D. T. Samuel,et al.  Short-term adaptation and temporal processing in the cryophilic response of Caenorhabditis elegans. , 2007, Journal of neurophysiology.

[44]  Randy D Blakely,et al.  Vigorous Motor Activity in Caenorhabditis elegans Requires Efficient Clearance of Dopamine Mediated by Synaptic Localization of the Dopamine Transporter DAT-1 , 2007, The Journal of Neuroscience.

[45]  Megan Gustafson,et al.  Serotonin signaling in C. elegans , 2007 .

[46]  W. Schultz.  Behavioral dopamine signals , 2007, Trends in Neurosciences.

[47]  Subhajyoti De,et al.  Dopamine Mediates Context-Dependent Modulation of Sensory Plasticity in C. elegans , 2007, Neuron.

[48]  M. Brauner,et al.  Caenorhabditis elegans selects distinct crawling and swimming gaits via dopamine and serotonin , 2011, Proceedings of the National Academy of Sciences.